Showing results (991-1000 of 5,723) with videos related to

Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|October 15, 2020
Economic perspective of cancer treatment in IndiaAparna Natarajan, Nikita Mehra, Thangarajan Rajkumar
Medical Oncology (Northwood, London, England)|July 31, 2021
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitroRichard C Zieren, Liang Dong, David J Clark, et al.
Medical Oncology (Northwood, London, England)|February 8, 2020
Could the kinetin riboside be used to inhibit human prostate cell epithelial-mesenchymal transition?Joanna Dulińska-Litewka, Bartosz Gąsiorkiewicz, Aleksandra Litewka, et al.
Medical Oncology (Northwood, London, England)|May 14, 2022
The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinomaHui Huang, Tao Chen, Fei Li, et al.
Medical Oncology (Northwood, London, England)|May 14, 2022
Novel immune subtypes identification of HER2-positive breast cancer based on immunogenomic landscapeLingli Huang, Xin Liu, Li Li, et al.
Medical Oncology (Northwood, London, England)|May 14, 2022
PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancerSutapa Mahata, Pranab K Sahoo, Ranita Pal, et al.
Medical Oncology (Northwood, London, England)|May 14, 2022
Cell line models for drug discovery in PIK3CA-mutated colorectal cancersIoannis A Voutsadakis
Medical Oncology (Northwood, London, England)|May 14, 2022
The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological ImplicationsSeyed Hossein Shahcheraghi, Fateme Salemi, Waqas Alam, et al.
Medical Oncology (Northwood, London, England)|May 14, 2022
20(s)-ginsenoside Rh2 promotes TRAIL-induced apoptosis by upregulating DR5 in human hepatocellular carcinoma cellsWenmo Liu, Siqi Wang, Qinchuan Yang, et al.
Pageof 573